Cargando…
DELFOS—drug efficacy leveraging forked and specialized networks—benchmarking scRNA-seq data in multi-omics-based prediction of cancer sensitivity
MOTIVATION: Cancer is currently one of the most notorious diseases, with over 1 million deaths in the European Union alone in 2022. As each tumor can be composed of diverse cell types with distinct genotypes, cancer cells can acquire resistance to different compounds. Moreover, anticancer drugs can...
Autores principales: | Piochi, Luiz Felipe, Preto, António J, Moreira, Irina S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627353/ https://www.ncbi.nlm.nih.gov/pubmed/37862234 http://dx.doi.org/10.1093/bioinformatics/btad645 |
Ejemplares similares
-
Recommendations of scRNA-seq Differential Gene Expression Analysis Based on Comprehensive Benchmarking
por: Gagnon, Jake, et al.
Publicado: (2022) -
scIMC: a platform for benchmarking comparison and visualization analysis of scRNA-seq data imputation methods
por: Dai, Chichi, et al.
Publicado: (2022) -
Viaje a Delfos
por: Trías, Carlos, 1946-
Publicado: (1994) -
ScRNA-seq and ST-seq in liver research
por: He, Jia, et al.
Publicado: (2023) -
Double-jeopardy: scRNA-seq doublet/multiplet detection using multi-omic profiling
por: Sun, Bo, et al.
Publicado: (2021)